ʻO ka maʻi hauā maʻi Neurosci. 2014 Jun;68(6):471-8. doi: 10.1111/pcn.12153.
Tang J1, Zhang Y, Li Y, Liu L, Liu X, Zeng H, Xiang D, Li CS, Lee TS.
Hōʻuluʻulu Manaʻo
AIM:
Ua noiʻi ʻia kēia noiʻi i nā hōʻike haumanu o ka hōʻiliʻili pūnaewele ma ka hoʻohana ʻana i ka loiloi cross-sectional a me ka nīnau kūkā ʻana.
KANAKA:
ʻO kahi nīnau ninaninau i hoʻonohonoho ʻia me nā heluna kanaka, Symptom Checklist 90, Scale Pilikino Pilikino Pilikino, Pilikia Pilikia Pilikia Pilikino Pilikino, a me ka ʻ'slelo Hoʻohui Hoʻohālikelike Pūnaewele ʻo Young (YIAT) i nā haumāna o nā kula kiʻekiʻe ʻelua ma Wuhan, Kina. Ua hoʻonohonoho ʻia nā haumāna me ka helu he 5 a ʻoi paha ma luna o ka YIAT ma ke ʻano he maʻi hōʻeha pūnaewele (IAD). Ua nīnauele ʻelua psychiatrist i nā haumāna me IAD e hōʻoia i ke kuhi a loiloi i kā lākou ʻano maʻi.
Nā hopena:
ʻO ka hōʻuluʻulu o 1076 mau pane (ʻo ia hoʻi ka makahiki 15.4 ± 1.7 makahiki; 54.1% keiki), 12.6% (n = 136) hālāwai i nā papahana YIAT no IAD. Ua hoʻomaopopoʻia nā nīnau ninaninau pūnaewele i ka hōʻano pūnaewele o nā haumāna 136 a ua hōʻike pūʻia nā haumāna 20 (14.7% o ka IAD) me nā maʻi psychiatric. ʻO nā hualoaʻa mai ka hoʻolālā loiloi multinomial i hōʻikeʻia he kāne, ma ka 7-9 mākau,ʻo ka pilina pilina ma waena o nā mākua a me nā helu hoʻohaʻahaʻa i hōʻikeʻia he nui i pili i ka hōʻailona o IAD.
Ka Hopena:
Ke hoʻomau nei kēia mau hopena i ko mākou ʻike pili i nā ʻano lāʻau lapaʻau o nā mea pili i ka Pūnaewele ma ke kula haʻahaʻa a ʻoi aku paha e kōkua i nā kauka, nā kumu kula, a me nā poʻe ʻē aʻe i mālama maikaʻi i kēia kūlana noʻonoʻo.
© 2014 ʻO nā mea kākau. Nā Psychiatry me Nā Neurosciences Clinical © 2014 Kepani Kepani o Psychiatry a me Neurology.
KEYWORDS:
Kina; Pākuʻi Pūnaewele; opio opio; ʻO ka comorbidity psychiatric
;